Serge Saxonov is CEO at 10x Genomics, Inc. (TXG). They have made 47 open-market trades across 1 company since 2020, most recently 2026-09-22.
CIK 0001786720
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 47 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TXG | 1,050,249 | $73.4M |
Shares reported on the most recent Form 4, priced at the 2026-09-24 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TXG | SELL · 10b5-1 | 2026-09-22 | 2026-09-24 | $81.22 | $2.0M | -4.4% | — | — |
| TXG | SELL · 10b5-1 | 2026-08-26 | 2026-08-28 | $63.69 | $668K | +9.0% | +45.4% | — |
| TXG | SELL | 2026-08-24 | 2026-08-26 | $63.02 | $1.2M | +2.6% | +34.2% | — |
| TXG | SELL · 10b5-1 | 2026-06-22 | 2026-06-24 | $34.44 | $1.0M | +8.7% | +33.0% | +132.2% |
| TXG | SELL · 10b5-1 | 2026-05-22 | 2026-05-27 | $24.54 | $709K | +15.1% | +45.0% | +155.6% |
| TXG | SELL · 10b5-1 | 2026-04-14 | 2026-04-16 | $24.56 | $123K | -18.0% | -17.7% | +75.1% |
| TXG | SELL · 10b5-1 | 2026-03-23 | 2026-03-25 | $19.26 | $578K | +6.0% | +7.3% | +54.9% |
| TXG | SELL · 10b5-1 | 2026-03-02 | 2026-03-04 | $22.73 | $367K | -23.5% | +0.3% | +40.7% |
| TXG | SELL | 2026-02-23 | 2026-02-25 | $18.58 | $179K | +6.4% | -0.9% | +25.3% |
| TXG | SELL | 2025-11-24 | 2025-11-25 | $19.00 | $252K | -6.0% | -11.3% | +1.7% |
| TXG | SELL | 2025-08-22 | 2025-08-26 | $13.79 | $258K | -0.0% | -14.2% | +44.5% |
| TXG | SELL | 2025-05-22 | 2025-05-27 | $8.30 | $155K | +9.4% | +35.9% | +63.4% |
| TXG | SELL · 10b5-1 | 2025-02-28 | 2025-03-04 | $10.63 | $169K | -3.2% | -25.4% | -11.5% |
| TXG | SELL | 2025-02-24 | 2025-02-26 | $11.07 | $113K | -7.4% | -19.9% | -24.9% |
| TXG | SELL | 2024-11-22 | 2024-11-25 | $13.69 | $183K | +5.4% | -2.5% | -25.0% |
| TXG | SELL | 2024-08-22 | 2024-08-26 | $22.53 | $304K | -4.2% | -5.5% | -32.0% |
| TXG | SELL | 2024-05-22 | 2024-05-23 | $24.30 | $237K | -3.4% | -13.5% | +0.2% |
| TXG | SELL | 2024-03-04 | 2024-03-06 | $44.00 | $205K | -12.7% | -12.3% | -48.0% |
| TXG | SELL | 2024-02-22 | 2024-02-26 | $46.34 | $261K | -10.2% | -19.1% | -50.2% |
| TXG | SELL · 10b5-1 | 2024-02-15 | 2024-02-20 | $48.87 | $244K | -2.4% | -18.6% | -46.8% |
| TXG | SELL · 10b5-1 | 2024-02-09 | 2024-02-13 | $49.53 | $50K | -4.7% | -21.9% | -43.4% |
| TXG | SELL · 10b5-1 | 2024-01-16 | 2024-01-18 | $45.18 | $315K | +2.2% | +12.2% | -31.1% |
| TXG | SELL · 10b5-1 | 2023-12-14 | 2023-12-18 | $55.04 | $110K | +1.9% | -23.7% | -34.3% |
| TXG | SELL | 2023-11-22 | 2023-11-27 | $43.53 | $651K | +13.2% | +35.9% | +8.1% |
| TXG | SELL · 10b5-1 | 2023-11-14 | 2023-11-16 | $39.52 | $79K | +7.3% | +33.6% | +19.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.